White Paper

A new era in signal detection

September 12, 2018

The launch of Eudravigilance, EMA’s database of adverse drug reactions, will grant the pharma industry access to a huge dataset of millions of case reports. Pharmathen’s accumulated expertise in pharmacovigilance consultancy will enable it to negotiate the underlying regulatory challenges and implications in the field of signal detection.

Download to find out more.